more emphasis on patients with A fib NOT stopping Pradaxa (dabigatran), Xarelto (rivaroxaban), or Eliquis (apixaban)
  You'll see more emphasis on patients with A fib NOT stopping Pradaxa (dabigatran), Xarelto (rivaroxaban), or Eliquis (apixaban).
  Stopping these new anticoagulants...even for a few days...can quickly return patients to their risk of stroke before starting therapy.
  That's because these anticoagulants are short-acting...with half-lives of about 12 hours compared to about 40 hours with warfarin.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive